The cost of borderline personality disorder: societal cost of illness in BPD-patients - 24/04/09
pages | 8 |
Iconographies | 1 |
Vidéos | 0 |
Autres | 0 |
Abstract |
Background |
Borderline personality disorder (BPD) is a highly prevalent, chronic condition. Because of its very problematic nature BPD is expected to be associated with substantial societal costs, although this has never been comprehensively assessed.
Objective |
Estimate the societal cost of BPD in the Netherlands.
Study Design |
We used a prevalence-based bottom-up approach with a sample of 88 BPD patients who enrolled in a multicenter clinical trial comparing two kinds of outpatient psychotherapy. Costs were assessed by means of a structured interview, covering all healthcare costs, medication, informal care, productivity losses, and out-of-pocket expenses. Only BPD-related costs were included. All costs were expressed in Euros for the year 2000. A bootstrap procedure was performed to determine statistical uncertainty.
Patients |
All patients had been diagnosed with BPD using DSM-IV criteria. Mean age was 30.5years and 92% was female.
Results |
Based on a prevalence of 1.1% and an adult population of 11,990,942, we derived that there were 131,900 BPD patients in the Netherlands. Total bootstrapped yearly cost of illness was €2,222,763,789 (€1,372,412,403–€3,260,248,300), only 22% was healthcare-related. Costs per patient were €16,852.
Conclusions |
Although healthcare costs of non-institutionalized Borderline patients might not be disproportionate, total societal costs are substantial.
Le texte complet de cet article est disponible en PDF.Keywords : Borderline personality disorder, Economics and psychiatry, Health economics
Plan
Vol 22 - N° 6
P. 354-361 - septembre 2007 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?